Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03211663 · ClinicalTrials.gov registry record
Performance of MOTO Medial® Unicompartmental Knee Arthroplasty
A clinical trial of Knee Osteoarthritis and Knee Pain Chronic, sponsored by Medacta U.
- Active
- Registry status
- 269
- Enrollment target
- 5
- Study locations
NCT03211663: Active study of Knee Osteoarthritis and Knee Pain Chronic, sponsored by Medacta U.
NCT03211663 is a study of Knee Osteoarthritis and Knee Pain Chronic that is active but no longer recruiting, run by Medacta U. The registered enrollment target is 269 participants, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (11% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03211663, a study of Knee Osteoarthritis and Knee Pain Chronic, is active but no longer recruiting, sponsored by Medacta U.
- ACTIVE NOT RECRUITING
- Registry status
- 269 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a prospective, multi-center study, designed to assess mid-term performance of the MOTO Medial® Unicompartmental Knee Arthroplasty (UKA), with patient report outcomes, clinical findings and radiographic analysis.
Primary Outcome
Assessment of improvement of clinical outcomes following knee replacement surgery using the Knee Society Score Questionnaire
Conditions Studied
Interventions
- DEVICE MOTO Medial® UKA
Study Locations (5)
Florida
- Unova Health Clinic - Lady Lake
Kentucky
- Ellis & Badenhausen Orthopaedics PSC - Louisville
Montana
- Ortho Montana - Billings
North Carolina
- Duke University - Durham
Pennsylvania
- Whole Health Joint Replacement - Meadville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2017-10-09 |
| Est. Completion | 2025-12-01 |
What the registry record for NCT03211663 still lists
NCT03211663 is an observational study that tracks outcomes without assigning an intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (11% lower).
The record links to 3 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which MOTO Medial® UKA is the first listed.
NCT03211663 lists 5 locations in 5 states (Florida, Kentucky, Montana).
Frequently Asked Questions
What is clinical trial NCT03211663 about?
NCT03211663 is a clinical study titled "Performance of MOTO Medial® Unicompartmental Knee Arthroplasty". This is a prospective, multi-center study, designed to assess mid-term performance of the MOTO Medial® Unicompartmental Knee Arthroplasty (UKA), with patient report outcomes, clinical findings and radiographic analysis.
What is the current status of trial NCT03211663?
This trial is currently active not recruiting. The enrollment target is 269 participants. The study started on 2017-10-09. Estimated completion is 2025-12-01.
What conditions does trial NCT03211663 study?
This clinical trial studies the following conditions: Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis.
What interventions are being tested in trial NCT03211663?
The interventions under investigation include: MOTO Medial® UKA (DEVICE).
Who is sponsoring clinical trial NCT03211663?
This trial is sponsored by Medacta U, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03211663 being conducted?
This trial has 5 study locations across Florida, Kentucky, Montana, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03211663's enrollment target sits among peer trials
269 17th of 101 higher than 85 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
RECRUITING · Early Phase 1
-
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
RECRUITING · Phase 4
-
Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis
RECRUITING
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04802291 · 269 participants · NA
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
- NCT06500455 · 269 participants · Phase 3
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
- NCT06630676 · 269 participants · NA
The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI